Efficacy of Erector Spinae Plane Block Analgesia After Off Pump Cardiac Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-22

Study Completion Date

2023-12-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigators will investigate the efficacy of ESPB as a part of Enhanced recovery after surgery on postoperative analgesia and recovery criteria after off pump cardiac surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Erector Spinae Plane Block in Post-operative Recovery in Cardiac Surgery With Median Sternotomy.

NCT05356715

Sternotomy Postoperative Pain

COMPLETED NA

Comparing Different Regional Blocks for Analgesia After Off-pump Cardiac Surgery

NCT05763810

Analgesia

ACTIVE_NOT_RECRUITING NA

Ultrasound Guided Erector Spinae Block for Postoperative Analgesia in Thoracotomy Patients

NCT03749395

Postoperative Pain

COMPLETED NA

the Effect of Erector Spinae Plane Block on Fentanyl Consumption During Abdominal Hysterectomy

NCT05072184

Post Operative Pain

COMPLETED NA

Erector Spinae Plane Block in Cardiac Surgery

NCT03997019

Pain, Acute

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

General anaesthesia will be induced by 0.05 mg/kg midazolam, 3 µg/kg fentanyl, 1-2mg/kg propofol, and 0.5mg/kg of Atracurium. After induction, bilateral erector spinae plane block will be performed in the block group. Intraoperative analgesia will be achieved by fentanyl boluses of 0.5-to-1 µg/kg titrated according to haemodynamic parameters. Postoperative analgesia will be managed by paracetamol 1000 mg /6hours and morphine 1-2mg boluses when pain score ≥4 1 to 2 mg to be repeated every 5 minutes if needed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector spinae block group

the patients will be administered bilateral Erector spinae block with 20 ml of 0.25 % bupivacaine

Group Type ACTIVE_COMPARATOR

Erector spinae block

Intervention Type PROCEDURE

After induction, the patients will be administered bilateral Erector spinae block with 20 ml of 0.25 % bupivacaine

Fentanyl

Intervention Type DRUG

fentanyl boluses of 0.5-to-1 µg/kg titrated according to haemodynamic parameters.

control group

no block will be done but only IV analgesia.

Group Type OTHER

Fentanyl

Intervention Type DRUG

fentanyl boluses of 0.5-to-1 µg/kg titrated according to haemodynamic parameters.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erector spinae block

After induction, the patients will be administered bilateral Erector spinae block with 20 ml of 0.25 % bupivacaine

Intervention Type PROCEDURE

Fentanyl

fentanyl boluses of 0.5-to-1 µg/kg titrated according to haemodynamic parameters.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-70 years
* ejection fraction of \> 45%
* undergoing elective off-pump cardiopulmonary bypass surgery

Exclusion Criteria

* vertebral anomalies
* intra-aortic balloon pump in the preoperative period
* acute myocardial infarction
* local infection at the site of block
* allergy to the local anesthetic used
* morbid obesity, psychiatric disorders, neurologic deficits, alcohol and chronic opioid abuse, and patients with bleeding diathesis.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No